Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Related Articles by Review for PubMed (Select 16298721)

1.

The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.

Catley D, Harris KJ, Okuyemi KS, Mayo MS, Pankey E, Ahluwalia JS.

Nicotine Tob Res. 2005 Dec;7(6):859-70.

PMID:
16298721
2.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
3.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
4.
5.

Review of bupropion for smoking cessation.

Richmond R, Zwar N.

Drug Alcohol Rev. 2003 Jun;22(2):203-20. Review.

PMID:
12850907
6.

Does bupropion have advantages over other medical therapies in the cessation of smoking?

Tonstad S, Johnston JA.

Expert Opin Pharmacother. 2004 Apr;5(4):727-34. Review.

PMID:
15102559
7.

The use of bupropion hydrochloride for smoking cessation therapy.

Nichols MR.

Clin Excell Nurse Pract. 1999 Nov;3(6):317-22. Review.

PMID:
10865568
8.

Bupropion as an aid to smoking cessation: a review of real-life effectiveness.

Holmes S, Zwar N, Jiménez-Ruiz CA, Ryan PJ, Browning D, Bergmann L, Johnston JA.

Int J Clin Pract. 2004 Mar;58(3):285-91. Review.

PMID:
15117097
9.
10.

Bupropion.

Wilkes S.

Drugs Today (Barc). 2006 Oct;42(10):671-81. Review.

PMID:
17136226
11.

Bupropion: risks and benefits.

Ross S, Williams D.

Expert Opin Drug Saf. 2005 Nov;4(6):995-1003. Review.

PMID:
16255659
12.

The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.

Balfour DJ.

Int J Clin Pract. 2001 Jan-Feb;55(1):53-7. Review.

PMID:
11219320
13.

Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation.

Johnston AJ, Ascher J, Leadbetter R, Schmith VD, Patel DK, Durcan M, Bentley B.

Drugs. 2002;62 Suppl 2:11-24. Review.

PMID:
12109932
14.

Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis.

Tsoi DT, Porwal M, Webster AC.

Br J Psychiatry. 2010 May;196(5):346-53. doi: 10.1192/bjp.bp.109.066019. Review.

15.

How does bupropion work as a smoking cessation aid?

Warner C, Shoaib M.

Addict Biol. 2005 Sep;10(3):219-31. Review.

PMID:
16109583
16.

The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations.

Colrain IM, Trinder J, Swan GE.

Nicotine Tob Res. 2004 Dec;6(6):913-25. Review.

PMID:
15801567
17.

Treating tobacco dependence in women.

Schnoll RA, Patterson F, Lerman C.

J Womens Health (Larchmt). 2007 Oct;16(8):1211-8. Review.

PMID:
17937574
18.

Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile.

Martinez-Raga J, Keaney F, Sutherland G, Perez-Galvez B, Strang J.

Addict Biol. 2003 Mar;8(1):13-21. Review.

PMID:
12745411
19.

A tragic triad: coronary artery disease, nicotine addiction, and depression.

Thorndike AN, Rigotti NA.

Curr Opin Cardiol. 2009 Sep;24(5):447-53. doi: 10.1097/HCO.0b013e32832ed645. Review.

PMID:
19550307
20.

Pharmacotherapy for smoking cessation during pregnancy.

Benowitz N, Dempsey D.

Nicotine Tob Res. 2004 Apr;6 Suppl 2:S189-202. Review. No abstract available.

PMID:
15203821
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk